- Home
- VKTX vs NMRK Comparison
VKTX vs NMRK Comparison
Compare VKTX & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- NMRK
- Stock Information
- Founded
- VKTX 2012
- NMRK 1929
- Country
- VKTX United States
- NMRK United States
- Employees
- VKTX N/A
- NMRK N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- NMRK Real Estate
- Sector
- VKTX Health Care
- NMRK Finance
- Exchange
- VKTX Nasdaq
- NMRK Nasdaq
- Market Cap
- VKTX 3.8B
- NMRK 3.4B
- IPO Year
- VKTX 2015
- NMRK 2017
- Fundamental
- Price
- VKTX $38.17
- NMRK $18.07
- Analyst Decision
- VKTX Strong Buy
- NMRK Strong Buy
- Analyst Count
- VKTX 14
- NMRK 5
- Target Price
- VKTX $87.00
- NMRK $19.00
- AVG Volume (30 Days)
- VKTX 5.0M
- NMRK 1.1M
- Earning Date
- VKTX 10-22-2025
- NMRK 10-30-2025
- Dividend Yield
- VKTX N/A
- NMRK 0.66%
- EPS Growth
- VKTX N/A
- NMRK 94.50
- EPS
- VKTX N/A
- NMRK 0.59
- Revenue
- VKTX N/A
- NMRK $3,160,782,000.00
- Revenue This Year
- VKTX N/A
- NMRK $17.66
- Revenue Next Year
- VKTX N/A
- NMRK $9.19
- P/E Ratio
- VKTX N/A
- NMRK $30.67
- Revenue Growth
- VKTX N/A
- NMRK 20.95
- 52 Week Low
- VKTX $18.92
- NMRK $9.65
- 52 Week High
- VKTX $79.10
- NMRK $19.84
- Technical
- Relative Strength Index (RSI)
- VKTX 66.94
- NMRK 45.68
- Support Level
- VKTX $33.00
- NMRK $17.70
- Resistance Level
- VKTX $36.11
- NMRK $19.84
- Average True Range (ATR)
- VKTX 2.05
- NMRK 0.64
- MACD
- VKTX 0.25
- NMRK -0.01
- Stochastic Oscillator
- VKTX 83.94
- NMRK 35.47
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.